The significance of exons skipping therapy in the treatment of Duchenne muscular dystrophy

被引：0
|
作者：
Takeda, Shinichi [1 ,2 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Kodaira, Tokyo 1878502, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan
来源：
NEUROSCIENCE RESEARCH | 2010年 / 68卷
关键词：
D O I：
10.1016/j.neures.2010.07.008
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [31] Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy
    Czifrus, Eszter
    Berlau, Daniel J. J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (10) : 853 - 858
  • [32] Clinical trials of exon skipping in Duchenne muscular dystrophy
    Mendell, Jerry R.
    Sahenk, Zarife
    Rodino-Klapac, Louise R.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 683 - 690
  • [33] Comparing clinical phenotype of patients with Duchenne muscular dystrophy with deletions amenable to skipping exons 44, 45, and 53
    Wang, S.
    Wong, B.
    McDonald, C.
    Yang, Y.
    Goemans, N.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S95 - S95
  • [34] 30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping
    Matsuo, Masafumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [35] Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy
    Heemskerk, Hans
    de Winter, Christa L.
    van Ommen, Gert-Jan B.
    van Deutekom, Judith C. T.
    Aartsma-Rus, Annemieke
    OLIGONUCLEOTIDE THERAPEUTICS, 2009, 1175 : 71 - 79
  • [36] Exon skipping therapy for Duchenne muscular dystrophy - it takes more than an antisense oligonucleotide
    Aartsma-Rus, Annemieke
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [37] Antisense-mediated exon skipping as a gene correction therapy for Duchenne muscular dystrophy
    van Deutekom, J
    Aartsma-Rus, A
    Bremmer-Bout, M
    Janson, A
    den Dunnen, J
    van Ommen, GJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S75 - S76
  • [38] ANTISENSE-BASED EXON SKIPPING AS A THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY, STATUS AND PROSPECTS
    van Ommen, G. -J.
    Aartsma-Rus, A.
    Evers, M.
    van Roon, W.
    'tHoen, P. -B.
    Kemaladewi, D.
    Verbeek, S.
    Yllmaz-Elis, S.
    Dauwerse, H.
    Lesnik-Oberstein, S.
    den Dunnen, J. T.
    Goemans, N.
    Tulinus, M.
    Verschuuren, J.
    de Kimpe, S.
    Campion, G.
    van Deutekom, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 7 - 7
  • [39] Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
    Yokota, Toshifumi
    Pistilli, Emidio
    Duddy, William
    Nagaraju, Kanneboyina
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) : 831 - 842
  • [40] Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    van Ommen, Gert-Jan B.
    LANCET NEUROLOGY, 2009, 8 (10): : 873 - 875
12345